Australia, July 22 -- Rybodyn Inc., owns the trademark (2543180) for 'DARK TARGET' till April 28, 2035.
Status: registered:
Registered/protected
Classes: 5 [Pharmaceuticals for the treatment of cancers and tumors; medical preparations, namely, vaccines, antigens, immunotherapeutic agents for the treatment and prevention of cancers and tumors] and 42 [Scientific and technological services and research and design relating thereto in the fields of genetics, immunotherapy, vaccination, and oncology; industrial research in the fields of genetics, immunotherapy, vaccination, and oncology; medical and pharmacological research services; medical research services; research and development of vaccines and medicines; research and development of anti...